nodes	percent_of_prediction	percent_of_DWPC	metapath
Emtricitabine—DCK—Desoximetasone—Methylprednisolone—psoriatic arthritis	0.00372	0.0885	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Dexamethasone—psoriatic arthritis	0.00366	0.0871	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Betamethasone—psoriatic arthritis	0.00366	0.0871	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Methylprednisolone—psoriatic arthritis	0.00361	0.0859	CbGdCrCtD
Emtricitabine—DCK—Desoximetasone—Triamcinolone—psoriatic arthritis	0.00358	0.0851	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Dexamethasone—psoriatic arthritis	0.00356	0.0845	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Betamethasone—psoriatic arthritis	0.00356	0.0845	CbGdCrCtD
Emtricitabine—Dermatitis—Auranofin—psoriatic arthritis	0.00352	0.00367	CcSEcCtD
Emtricitabine—Dermatitis bullous—Triamcinolone—psoriatic arthritis	0.00348	0.00364	CcSEcCtD
Emtricitabine—DCK—Diflorasone—Triamcinolone—psoriatic arthritis	0.00348	0.0826	CbGdCrCtD
Emtricitabine—Proteinuria—Methotrexate—psoriatic arthritis	0.00345	0.0036	CcSEcCtD
Emtricitabine—Neuropathy—Prednisone—psoriatic arthritis	0.0034	0.00355	CcSEcCtD
Emtricitabine—Protein urine present—Methotrexate—psoriatic arthritis	0.0034	0.00355	CcSEcCtD
Emtricitabine—DCK—Desoximetasone—Prednisone—psoriatic arthritis	0.0034	0.0808	CbGdCrCtD
Emtricitabine—Skin discolouration—Methotrexate—psoriatic arthritis	0.00335	0.0035	CcSEcCtD
Emtricitabine—Hyperbilirubinaemia—Methotrexate—psoriatic arthritis	0.00333	0.00348	CcSEcCtD
Emtricitabine—DCK—Desoximetasone—Prednisolone—psoriatic arthritis	0.00332	0.0788	CbGdCrCtD
Emtricitabine—Nausea—Auranofin—psoriatic arthritis	0.00332	0.00346	CcSEcCtD
Emtricitabine—DCK—Diflorasone—Prednisone—psoriatic arthritis	0.0033	0.0784	CbGdCrCtD
Emtricitabine—DCK—Diflorasone—Prednisolone—psoriatic arthritis	0.00322	0.0765	CbGdCrCtD
Emtricitabine—Muscular weakness—Prednisolone—psoriatic arthritis	0.00319	0.00333	CcSEcCtD
Emtricitabine—Dermatitis bullous—Dexamethasone—psoriatic arthritis	0.00316	0.0033	CcSEcCtD
Emtricitabine—Dermatitis bullous—Betamethasone—psoriatic arthritis	0.00316	0.0033	CcSEcCtD
Emtricitabine—Inflammation—Methotrexate—psoriatic arthritis	0.00312	0.00326	CcSEcCtD
Emtricitabine—Pancreatitis—Prednisolone—psoriatic arthritis	0.00307	0.0032	CcSEcCtD
Emtricitabine—Breast disorder—Methylprednisolone—psoriatic arthritis	0.003	0.00313	CcSEcCtD
Emtricitabine—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00294	0.00307	CcSEcCtD
Emtricitabine—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00293	0.00306	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00293	0.00306	CcSEcCtD
Emtricitabine—Pancreatitis—Triamcinolone—psoriatic arthritis	0.00282	0.00295	CcSEcCtD
Emtricitabine—Pancreatitis—Methylprednisolone—psoriatic arthritis	0.00282	0.00294	CcSEcCtD
Emtricitabine—Hypokalaemia—Betamethasone—psoriatic arthritis	0.00275	0.00287	CcSEcCtD
Emtricitabine—Hypokalaemia—Dexamethasone—psoriatic arthritis	0.00275	0.00287	CcSEcCtD
Emtricitabine—Urine output increased—Methotrexate—psoriatic arthritis	0.00274	0.00286	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Prednisolone—psoriatic arthritis	0.00274	0.00286	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Triamcinolone—psoriatic arthritis	0.00268	0.00279	CcSEcCtD
Emtricitabine—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00267	0.00278	CcSEcCtD
Emtricitabine—Muscular weakness—Betamethasone—psoriatic arthritis	0.00267	0.00278	CcSEcCtD
Emtricitabine—Infestation—Methylprednisolone—psoriatic arthritis	0.00256	0.00267	CcSEcCtD
Emtricitabine—Infestation NOS—Methylprednisolone—psoriatic arthritis	0.00256	0.00267	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Triamcinolone—psoriatic arthritis	0.00252	0.00263	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Methylprednisolone—psoriatic arthritis	0.00251	0.00262	CcSEcCtD
Emtricitabine—Polyuria—Methotrexate—psoriatic arthritis	0.0025	0.00261	CcSEcCtD
Emtricitabine—Hypokalaemia—Prednisone—psoriatic arthritis	0.00239	0.0025	CcSEcCtD
Emtricitabine—Renal failure acute—Methotrexate—psoriatic arthritis	0.00238	0.00249	CcSEcCtD
Emtricitabine—Weight decreased—Betamethasone—psoriatic arthritis	0.00236	0.00247	CcSEcCtD
Emtricitabine—Weight decreased—Dexamethasone—psoriatic arthritis	0.00236	0.00247	CcSEcCtD
Emtricitabine—Hyperglycaemia—Dexamethasone—psoriatic arthritis	0.00236	0.00246	CcSEcCtD
Emtricitabine—Hyperglycaemia—Betamethasone—psoriatic arthritis	0.00236	0.00246	CcSEcCtD
Emtricitabine—Muscular weakness—Prednisone—psoriatic arthritis	0.00232	0.00242	CcSEcCtD
Emtricitabine—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00232	0.00242	CcSEcCtD
Emtricitabine—Rhinitis—Triamcinolone—psoriatic arthritis	0.00231	0.00241	CcSEcCtD
Emtricitabine—Rhinitis—Methylprednisolone—psoriatic arthritis	0.0023	0.00241	CcSEcCtD
Emtricitabine—Pharyngitis—Triamcinolone—psoriatic arthritis	0.00229	0.00239	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Dexamethasone—psoriatic arthritis	0.00228	0.00238	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Betamethasone—psoriatic arthritis	0.00228	0.00238	CcSEcCtD
Emtricitabine—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00226	0.00236	CcSEcCtD
Emtricitabine—Pancreatitis—Prednisone—psoriatic arthritis	0.00223	0.00233	CcSEcCtD
Emtricitabine—Neutropenia—Prednisone—psoriatic arthritis	0.00213	0.00222	CcSEcCtD
Emtricitabine—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00208	0.00217	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methylprednisolone—psoriatic arthritis	0.00207	0.00216	CcSEcCtD
Emtricitabine—Weight decreased—Prednisone—psoriatic arthritis	0.00206	0.00215	CcSEcCtD
Emtricitabine—Hyperglycaemia—Prednisone—psoriatic arthritis	0.00205	0.00214	CcSEcCtD
Emtricitabine—Depression—Prednisone—psoriatic arthritis	0.00202	0.00211	CcSEcCtD
Emtricitabine—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00201	0.0021	CcSEcCtD
Emtricitabine—Malnutrition—Methylprednisolone—psoriatic arthritis	0.002	0.00209	CcSEcCtD
Emtricitabine—Angioedema—Prednisolone—psoriatic arthritis	0.00199	0.00208	CcSEcCtD
Emtricitabine—Neuropathy peripheral—Prednisone—psoriatic arthritis	0.00199	0.00208	CcSEcCtD
Emtricitabine—Breast disorder—Methotrexate—psoriatic arthritis	0.00199	0.00207	CcSEcCtD
Emtricitabine—Back pain—Triamcinolone—psoriatic arthritis	0.00194	0.00203	CcSEcCtD
Emtricitabine—Pancreatitis—Methotrexate—psoriatic arthritis	0.00186	0.00195	CcSEcCtD
Emtricitabine—Angioedema—Triamcinolone—psoriatic arthritis	0.00183	0.00191	CcSEcCtD
Emtricitabine—Angioedema—Methylprednisolone—psoriatic arthritis	0.00183	0.00191	CcSEcCtD
Emtricitabine—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00179	0.00187	CcSEcCtD
Emtricitabine—Neutropenia—Methotrexate—psoriatic arthritis	0.00178	0.00186	CcSEcCtD
Emtricitabine—Upper respiratory tract infection—Methotrexate—psoriatic arthritis	0.00177	0.00184	CcSEcCtD
Emtricitabine—Cough—Triamcinolone—psoriatic arthritis	0.00175	0.00183	CcSEcCtD
Emtricitabine—Myalgia—Triamcinolone—psoriatic arthritis	0.00171	0.00178	CcSEcCtD
Emtricitabine—Pneumonia—Methotrexate—psoriatic arthritis	0.0017	0.00178	CcSEcCtD
Emtricitabine—Myalgia—Methylprednisolone—psoriatic arthritis	0.0017	0.00178	CcSEcCtD
Emtricitabine—Arthralgia—Methylprednisolone—psoriatic arthritis	0.0017	0.00178	CcSEcCtD
Emtricitabine—Anxiety—Methylprednisolone—psoriatic arthritis	0.0017	0.00177	CcSEcCtD
Emtricitabine—Infestation NOS—Methotrexate—psoriatic arthritis	0.00169	0.00177	CcSEcCtD
Emtricitabine—Infestation—Methotrexate—psoriatic arthritis	0.00169	0.00177	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.00169	0.00177	CcSEcCtD
Emtricitabine—Depression—Methotrexate—psoriatic arthritis	0.00169	0.00176	CcSEcCtD
Emtricitabine—Renal failure—Methotrexate—psoriatic arthritis	0.00167	0.00174	CcSEcCtD
Emtricitabine—Angioedema—Dexamethasone—psoriatic arthritis	0.00166	0.00174	CcSEcCtD
Emtricitabine—Angioedema—Betamethasone—psoriatic arthritis	0.00166	0.00174	CcSEcCtD
Emtricitabine—Immune system disorder—Prednisone—psoriatic arthritis	0.00164	0.00172	CcSEcCtD
Emtricitabine—Infection—Triamcinolone—psoriatic arthritis	0.00163	0.0017	CcSEcCtD
Emtricitabine—Infection—Methylprednisolone—psoriatic arthritis	0.00162	0.00169	CcSEcCtD
Emtricitabine—Haematuria—Methotrexate—psoriatic arthritis	0.00162	0.00169	CcSEcCtD
Emtricitabine—Insomnia—Prednisolone—psoriatic arthritis	0.00161	0.00168	CcSEcCtD
Emtricitabine—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.0016	0.00167	CcSEcCtD
Emtricitabine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.0016	0.00167	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisolone—psoriatic arthritis	0.0016	0.00167	CcSEcCtD
Emtricitabine—Mental disorder—Prednisone—psoriatic arthritis	0.00159	0.00167	CcSEcCtD
Emtricitabine—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00159	0.00166	CcSEcCtD
Emtricitabine—Malnutrition—Prednisone—psoriatic arthritis	0.00158	0.00165	CcSEcCtD
Emtricitabine—Myalgia—Betamethasone—psoriatic arthritis	0.00155	0.00162	CcSEcCtD
Emtricitabine—Myalgia—Dexamethasone—psoriatic arthritis	0.00155	0.00162	CcSEcCtD
Emtricitabine—Anxiety—Dexamethasone—psoriatic arthritis	0.00154	0.00161	CcSEcCtD
Emtricitabine—Anxiety—Betamethasone—psoriatic arthritis	0.00154	0.00161	CcSEcCtD
Emtricitabine—Pain—Prednisolone—psoriatic arthritis	0.00152	0.00159	CcSEcCtD
Emtricitabine—Hepatitis—Methotrexate—psoriatic arthritis	0.00152	0.00159	CcSEcCtD
Emtricitabine—Pharyngitis—Methotrexate—psoriatic arthritis	0.00151	0.00158	CcSEcCtD
Emtricitabine—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.0015	0.00157	CcSEcCtD
Emtricitabine—Urethral disorder—Methotrexate—psoriatic arthritis	0.00149	0.00156	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00149	0.00156	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00149	0.00155	CcSEcCtD
Emtricitabine—Insomnia—Triamcinolone—psoriatic arthritis	0.00148	0.00155	CcSEcCtD
Emtricitabine—Insomnia—Methylprednisolone—psoriatic arthritis	0.00148	0.00154	CcSEcCtD
Emtricitabine—Infection—Betamethasone—psoriatic arthritis	0.00148	0.00154	CcSEcCtD
Emtricitabine—Infection—Dexamethasone—psoriatic arthritis	0.00148	0.00154	CcSEcCtD
Emtricitabine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00147	0.00153	CcSEcCtD
Emtricitabine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00147	0.00153	CcSEcCtD
Emtricitabine—Anaemia—Prednisone—psoriatic arthritis	0.00146	0.00153	CcSEcCtD
Emtricitabine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00146	0.00152	CcSEcCtD
Emtricitabine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.00146	0.00152	CcSEcCtD
Emtricitabine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.00146	0.00152	CcSEcCtD
Emtricitabine—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00145	0.00152	CcSEcCtD
Emtricitabine—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00145	0.00152	CcSEcCtD
Emtricitabine—Angioedema—Prednisone—psoriatic arthritis	0.00145	0.00151	CcSEcCtD
Emtricitabine—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00144	0.0015	CcSEcCtD
Emtricitabine—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00144	0.0015	CcSEcCtD
Emtricitabine—Urticaria—Prednisolone—psoriatic arthritis	0.00141	0.00148	CcSEcCtD
Emtricitabine—Fatigue—Triamcinolone—psoriatic arthritis	0.00141	0.00147	CcSEcCtD
Emtricitabine—Fatigue—Methylprednisolone—psoriatic arthritis	0.00141	0.00147	CcSEcCtD
Emtricitabine—Pain—Triamcinolone—psoriatic arthritis	0.0014	0.00146	CcSEcCtD
Emtricitabine—Immune system disorder—Methotrexate—psoriatic arthritis	0.00137	0.00143	CcSEcCtD
Emtricitabine—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.00137	0.00143	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00135	0.00141	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00135	0.00141	CcSEcCtD
Emtricitabine—Myalgia—Prednisone—psoriatic arthritis	0.00135	0.00141	CcSEcCtD
Emtricitabine—Arthralgia—Prednisone—psoriatic arthritis	0.00135	0.00141	CcSEcCtD
Emtricitabine—Anxiety—Prednisone—psoriatic arthritis	0.00134	0.0014	CcSEcCtD
Emtricitabine—Insomnia—Betamethasone—psoriatic arthritis	0.00134	0.0014	CcSEcCtD
Emtricitabine—Insomnia—Dexamethasone—psoriatic arthritis	0.00134	0.0014	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00134	0.0014	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00134	0.00139	CcSEcCtD
Emtricitabine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00133	0.00139	CcSEcCtD
Emtricitabine—Paraesthesia—Betamethasone—psoriatic arthritis	0.00133	0.00139	CcSEcCtD
Emtricitabine—Mental disorder—Methotrexate—psoriatic arthritis	0.00133	0.00139	CcSEcCtD
Emtricitabine—Malnutrition—Methotrexate—psoriatic arthritis	0.00132	0.00138	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00131	0.00137	CcSEcCtD
Emtricitabine—Dyspepsia—Betamethasone—psoriatic arthritis	0.00131	0.00136	CcSEcCtD
Emtricitabine—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00131	0.00136	CcSEcCtD
Emtricitabine—Urticaria—Triamcinolone—psoriatic arthritis	0.0013	0.00136	CcSEcCtD
Emtricitabine—Urticaria—Methylprednisolone—psoriatic arthritis	0.0013	0.00135	CcSEcCtD
Emtricitabine—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00129	0.00135	CcSEcCtD
Emtricitabine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00129	0.00135	CcSEcCtD
Emtricitabine—Infection—Prednisone—psoriatic arthritis	0.00128	0.00134	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00128	0.00134	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00128	0.00134	CcSEcCtD
Emtricitabine—Back pain—Methotrexate—psoriatic arthritis	0.00128	0.00134	CcSEcCtD
Emtricitabine—Fatigue—Dexamethasone—psoriatic arthritis	0.00128	0.00134	CcSEcCtD
Emtricitabine—Fatigue—Betamethasone—psoriatic arthritis	0.00128	0.00134	CcSEcCtD
Emtricitabine—Pain—Dexamethasone—psoriatic arthritis	0.00127	0.00133	CcSEcCtD
Emtricitabine—Pain—Betamethasone—psoriatic arthritis	0.00127	0.00133	CcSEcCtD
Emtricitabine—Nervous system disorder—Prednisone—psoriatic arthritis	0.00127	0.00132	CcSEcCtD
Emtricitabine—Skin disorder—Prednisone—psoriatic arthritis	0.00126	0.00131	CcSEcCtD
Emtricitabine—Anaemia—Methotrexate—psoriatic arthritis	0.00122	0.00128	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00121	0.00127	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00121	0.00127	CcSEcCtD
Emtricitabine—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00121	0.00126	CcSEcCtD
Emtricitabine—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.0012	0.00126	CcSEcCtD
Emtricitabine—Urticaria—Dexamethasone—psoriatic arthritis	0.00118	0.00123	CcSEcCtD
Emtricitabine—Urticaria—Betamethasone—psoriatic arthritis	0.00118	0.00123	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00118	0.00123	CcSEcCtD
Emtricitabine—Dizziness—Prednisolone—psoriatic arthritis	0.00118	0.00123	CcSEcCtD
Emtricitabine—Asthenia—Triamcinolone—psoriatic arthritis	0.00117	0.00123	CcSEcCtD
Emtricitabine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.00117	0.00123	CcSEcCtD
Emtricitabine—Abdominal pain—Betamethasone—psoriatic arthritis	0.00117	0.00123	CcSEcCtD
Emtricitabine—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00117	0.00123	CcSEcCtD
Emtricitabine—Body temperature increased—Betamethasone—psoriatic arthritis	0.00117	0.00123	CcSEcCtD
Emtricitabine—Asthenia—Methylprednisolone—psoriatic arthritis	0.00117	0.00122	CcSEcCtD
Emtricitabine—Insomnia—Prednisone—psoriatic arthritis	0.00117	0.00122	CcSEcCtD
Emtricitabine—Paraesthesia—Prednisone—psoriatic arthritis	0.00116	0.00121	CcSEcCtD
Emtricitabine—Pruritus—Triamcinolone—psoriatic arthritis	0.00116	0.00121	CcSEcCtD
Emtricitabine—Cough—Methotrexate—psoriatic arthritis	0.00116	0.00121	CcSEcCtD
Emtricitabine—Pruritus—Methylprednisolone—psoriatic arthritis	0.00116	0.00121	CcSEcCtD
Emtricitabine—Dyspepsia—Prednisone—psoriatic arthritis	0.00114	0.00119	CcSEcCtD
Emtricitabine—Arthralgia—Methotrexate—psoriatic arthritis	0.00113	0.00118	CcSEcCtD
Emtricitabine—Myalgia—Methotrexate—psoriatic arthritis	0.00113	0.00118	CcSEcCtD
Emtricitabine—Rash—Prednisolone—psoriatic arthritis	0.00112	0.00117	CcSEcCtD
Emtricitabine—Dermatitis—Prednisolone—psoriatic arthritis	0.00112	0.00117	CcSEcCtD
Emtricitabine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.00112	0.00117	CcSEcCtD
Emtricitabine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00112	0.00117	CcSEcCtD
Emtricitabine—Fatigue—Prednisone—psoriatic arthritis	0.00112	0.00116	CcSEcCtD
Emtricitabine—Headache—Prednisolone—psoriatic arthritis	0.00112	0.00116	CcSEcCtD
Emtricitabine—Dizziness—Triamcinolone—psoriatic arthritis	0.00108	0.00113	CcSEcCtD
Emtricitabine—Dizziness—Methylprednisolone—psoriatic arthritis	0.00108	0.00113	CcSEcCtD
Emtricitabine—Infection—Methotrexate—psoriatic arthritis	0.00107	0.00112	CcSEcCtD
Emtricitabine—Asthenia—Betamethasone—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Emtricitabine—Asthenia—Dexamethasone—psoriatic arthritis	0.00107	0.00111	CcSEcCtD
Emtricitabine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.00106	0.00111	CcSEcCtD
Emtricitabine—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.00106	0.0011	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.00106	0.0011	CcSEcCtD
Emtricitabine—Nausea—Prednisolone—psoriatic arthritis	0.00106	0.0011	CcSEcCtD
Emtricitabine—Pruritus—Betamethasone—psoriatic arthritis	0.00105	0.0011	CcSEcCtD
Emtricitabine—Pruritus—Dexamethasone—psoriatic arthritis	0.00105	0.0011	CcSEcCtD
Emtricitabine—Skin disorder—Methotrexate—psoriatic arthritis	0.00105	0.0011	CcSEcCtD
Emtricitabine—Vomiting—Triamcinolone—psoriatic arthritis	0.00104	0.00109	CcSEcCtD
Emtricitabine—Vomiting—Methylprednisolone—psoriatic arthritis	0.00104	0.00108	CcSEcCtD
Emtricitabine—Rash—Triamcinolone—psoriatic arthritis	0.00103	0.00108	CcSEcCtD
Emtricitabine—Dermatitis—Triamcinolone—psoriatic arthritis	0.00103	0.00108	CcSEcCtD
Emtricitabine—Rash—Methylprednisolone—psoriatic arthritis	0.00103	0.00107	CcSEcCtD
Emtricitabine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00103	0.00107	CcSEcCtD
Emtricitabine—Urticaria—Prednisone—psoriatic arthritis	0.00103	0.00107	CcSEcCtD
Emtricitabine—Headache—Triamcinolone—psoriatic arthritis	0.00103	0.00107	CcSEcCtD
Emtricitabine—Headache—Methylprednisolone—psoriatic arthritis	0.00102	0.00107	CcSEcCtD
Emtricitabine—Body temperature increased—Prednisone—psoriatic arthritis	0.00102	0.00107	CcSEcCtD
Emtricitabine—Abdominal pain—Prednisone—psoriatic arthritis	0.00102	0.00107	CcSEcCtD
Emtricitabine—Diarrhoea—Betamethasone—psoriatic arthritis	0.00102	0.00106	CcSEcCtD
Emtricitabine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00102	0.00106	CcSEcCtD
Emtricitabine—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000985	0.00103	CcSEcCtD
Emtricitabine—Dizziness—Betamethasone—psoriatic arthritis	0.000982	0.00103	CcSEcCtD
Emtricitabine—Dizziness—Dexamethasone—psoriatic arthritis	0.000982	0.00103	CcSEcCtD
Emtricitabine—Insomnia—Methotrexate—psoriatic arthritis	0.000978	0.00102	CcSEcCtD
Emtricitabine—Nausea—Triamcinolone—psoriatic arthritis	0.000972	0.00101	CcSEcCtD
Emtricitabine—Paraesthesia—Methotrexate—psoriatic arthritis	0.000971	0.00101	CcSEcCtD
Emtricitabine—Nausea—Methylprednisolone—psoriatic arthritis	0.00097	0.00101	CcSEcCtD
Emtricitabine—Dyspnoea—Methotrexate—psoriatic arthritis	0.000964	0.00101	CcSEcCtD
Emtricitabine—Hypersensitivity—Prednisone—psoriatic arthritis	0.000953	0.000995	CcSEcCtD
Emtricitabine—Dyspepsia—Methotrexate—psoriatic arthritis	0.000952	0.000993	CcSEcCtD
Emtricitabine—Vomiting—Dexamethasone—psoriatic arthritis	0.000944	0.000986	CcSEcCtD
Emtricitabine—Vomiting—Betamethasone—psoriatic arthritis	0.000944	0.000986	CcSEcCtD
Emtricitabine—Rash—Betamethasone—psoriatic arthritis	0.000936	0.000978	CcSEcCtD
Emtricitabine—Rash—Dexamethasone—psoriatic arthritis	0.000936	0.000978	CcSEcCtD
Emtricitabine—Dermatitis—Betamethasone—psoriatic arthritis	0.000936	0.000977	CcSEcCtD
Emtricitabine—Dermatitis—Dexamethasone—psoriatic arthritis	0.000936	0.000977	CcSEcCtD
Emtricitabine—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000933	0.000974	CcSEcCtD
Emtricitabine—Fatigue—Methotrexate—psoriatic arthritis	0.000932	0.000973	CcSEcCtD
Emtricitabine—Headache—Betamethasone—psoriatic arthritis	0.00093	0.000971	CcSEcCtD
Emtricitabine—Headache—Dexamethasone—psoriatic arthritis	0.00093	0.000971	CcSEcCtD
Emtricitabine—Asthenia—Prednisone—psoriatic arthritis	0.000928	0.000969	CcSEcCtD
Emtricitabine—Pain—Methotrexate—psoriatic arthritis	0.000924	0.000965	CcSEcCtD
Emtricitabine—Pruritus—Prednisone—psoriatic arthritis	0.000915	0.000955	CcSEcCtD
Emtricitabine—Diarrhoea—Prednisone—psoriatic arthritis	0.000885	0.000924	CcSEcCtD
Emtricitabine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000884	0.000923	CcSEcCtD
Emtricitabine—Nausea—Dexamethasone—psoriatic arthritis	0.000882	0.000921	CcSEcCtD
Emtricitabine—Nausea—Betamethasone—psoriatic arthritis	0.000882	0.000921	CcSEcCtD
Emtricitabine—Urticaria—Methotrexate—psoriatic arthritis	0.000859	0.000896	CcSEcCtD
Emtricitabine—Dizziness—Prednisone—psoriatic arthritis	0.000855	0.000893	CcSEcCtD
Emtricitabine—Body temperature increased—Methotrexate—psoriatic arthritis	0.000855	0.000892	CcSEcCtD
Emtricitabine—Abdominal pain—Methotrexate—psoriatic arthritis	0.000855	0.000892	CcSEcCtD
Emtricitabine—Vomiting—Prednisone—psoriatic arthritis	0.000822	0.000858	CcSEcCtD
Emtricitabine—Rash—Prednisone—psoriatic arthritis	0.000816	0.000851	CcSEcCtD
Emtricitabine—Dermatitis—Prednisone—psoriatic arthritis	0.000815	0.000851	CcSEcCtD
Emtricitabine—Headache—Prednisone—psoriatic arthritis	0.00081	0.000846	CcSEcCtD
Emtricitabine—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000796	0.000831	CcSEcCtD
Emtricitabine—Asthenia—Methotrexate—psoriatic arthritis	0.000776	0.00081	CcSEcCtD
Emtricitabine—Nausea—Prednisone—psoriatic arthritis	0.000768	0.000802	CcSEcCtD
Emtricitabine—Pruritus—Methotrexate—psoriatic arthritis	0.000765	0.000798	CcSEcCtD
Emtricitabine—Diarrhoea—Methotrexate—psoriatic arthritis	0.00074	0.000772	CcSEcCtD
Emtricitabine—Dizziness—Methotrexate—psoriatic arthritis	0.000715	0.000746	CcSEcCtD
Emtricitabine—Vomiting—Methotrexate—psoriatic arthritis	0.000687	0.000717	CcSEcCtD
Emtricitabine—Rash—Methotrexate—psoriatic arthritis	0.000682	0.000711	CcSEcCtD
Emtricitabine—Dermatitis—Methotrexate—psoriatic arthritis	0.000681	0.000711	CcSEcCtD
Emtricitabine—Headache—Methotrexate—psoriatic arthritis	0.000677	0.000707	CcSEcCtD
Emtricitabine—Nausea—Methotrexate—psoriatic arthritis	0.000642	0.00067	CcSEcCtD
